Health Condition 1: F99- Mental disorder, not otherwise specified
Conditions
Interventions
Intervention1: TAB. ONDANSETRON 4mg per oral once a day for 20 weeks
Tab. ARIPIPRAZOLE 10mg per oral once a day for 20 weeks: ONDANSETRON AUGMENTATION ALONG WITH STANDARD TREATMENT IN OBSESSIVE COMPUL
Sponsors
NIL
Eligibility
Inclusion criteria
Inclusion criteria: Patients of either gender Patients with age ranging between 18-60 years Patients who gave consent and were willing to participate
Exclusion criteria
Exclusion criteria: History of hypersensitivity or allergy to any of drugs we are going to use during study (Ondansetron, Aripiprazole) History of head trauma History of epilepsy History of any organic brain disease History of Schizophrenia, Bipolar Mood Disorder, Dementia, Acute Psychosis Pregnant and lactating women Liver disease Renal dysfunction Evidence of an end stage disease of a major system (hepatic, renal, respiratory, haematologic (PA), immunologic, cardiovascular, inflammatory, rheumatology, active infections, peripheral vascular disease, untreated endocrine (hypothyroid).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Aripirazole being an antipsychotic is expected to have better outcomesTimepoint: at baseline, 6 weeks, 12 weeks & 20 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| YBOCS Scale, CGI-S Scale,CGI-I Scale at 20 WeeksTimepoint: 6 weeks, 12 weeks, 20 weeeks | — |
Countries
India
Contacts
Public ContactChandraveer Singh
UPUMS SAIFAI
Outcome results
None listed